| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 3'-去甲川陈皮素; 3'-Demethylnobiletin | CFN93130 | 112448-39-2 | C20H20O8 = 388.37 | 10mg | QQ客服：215959384 |
| 4β-羟基黄芪紫檀烷苷; Astraganoside | CFN93136 | 1011711-05-9 | C23H28O11 = 480.46 | 5mg | QQ客服：1413575084 |
| 大豆苷元二乙酯; Daidzein diacetate | CFN93138 | 3682-01-7 | C19H14O6 = 338.31 | 5mg | QQ客服：1457312923 |
| Epitheaflagallin 3-O-gallate; Epitheaflagallin 3-O-gallate | CFN93141 | 102067-92-5 | C27H20O13 = 552.44 | 5mg | QQ客服：1413575084 |
| Cochliophilin A; Cochliophilin A | CFN93156 | 110204-45-0 | C16H10O5 = 282.25 | 5mg | QQ客服：2056216494 |
| 麦冬二氢高异黄酮B; Ophiopogonanone B | CFN93175 | 1316759-83-7 | C18H18O5 = 314.33 | 5mg | QQ客服：1413575084 |
| 蔓性千斤拔素A; Flemiphilippinin A | CFN93184 | 140366-64-9 | C30H32O6 = 488.58 | 5mg | QQ客服：2159513211 |
| 4'-甲基醚金连木黄酮; 4'-O-Methylochnaflavone | CFN93227 | 49619-87-6 | C31H20O10 = 552.49 | 5mg | QQ客服：1457312923 |
| 药芹二糖苷A; Graveobioside A | CFN93242 | 506410-53-3 | C26H28O15 = 580.49 | 5mg | QQ客服：215959384 |
| 甘草黄酮A; Licoflavone A | CFN93265 | 61153-77-3 | C20H18O4 = 322.36 | 5mg | QQ客服：215959384 |
| 桑皮酮G; Kuwanon G | CFN93278 | 75629-19-5 | C40H36O11 = 692.71 | 20mg | QQ客服：2056216494 |
| 甘草黄酮B; Licoflavone B | CFN93300 | 91433-17-9 | C25H26O4 = 390.47 | 20mg | QQ客服：1413575084 |
| 红车轴草素-7-O-β-D-吡喃葡糖苷; Pratensein 7-O-glucopyranoside | CFN91047 | 36191-03-4 | C22H22O11 = 462.41 | 5mg | QQ客服：215959384 |
| Parvisoflavanone; Parvisoflavanone | CFN95077 | 49776-79-6 | C17H16O7 = 332.3 | 5mg | QQ客服：215959384 |
| 牡荆素葡萄糖苷; 4'-O-Glucosylvitexin | CFN93084 | 38950-94-6 | C27H30O15 = 594.52 | 5mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)